Proteolytic Processing of Neuregulin 2

Neuregulin 2 (NRG2) belongs to the EGF family of growth factors. Most of this family members require proteolytic cleavage to liberate their ectodomains capable of binding and activating their cognate ErbB receptors. To date, most of the studies investigating proteolytic processing of neuregulins focused on NRG1, which was shown to undergo ectodomain shedding by several ADAM proteases and BACE1 and the remaining fragment was further cleaved by γ-secretase. Recently, NRG2 attracted more attention due to its role in the neurogenesis and modulation of behaviors associated with psychiatric disorders. In this study, we used genetic engineering methods to identify proteases involved in proteolytic processing of murine NRG2. Using non-neuronal cell lines as well as cultures of primary hippocampal neurons, we demonstrated that the major proteases responsible for releasing NRG2 ectodomain are ADAM10 and BACE2. Co-expression of NRG2 and BACE2 in neurons of certain brain structures including medulla oblongata and cerebellar deep nuclei was confirmed via immunohistochemical staining. The cleavage of NRG2 by ADAM10 or BACE2 generates a C-terminal fragment that serves as a substrate for γ-secretase. We also showed that murine NRG2 is subject to post-translational modifications, substantial glycosylation of its extracellular part, and phosphorylation of the cytoplasmic tail.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:57

Enthalten in:

Molecular neurobiology - 57(2020), 4 vom: 14. Apr., Seite 1799-1813

Sprache:

Englisch

Beteiligte Personen:

Czarnek, Maria [VerfasserIn]
Bereta, Joanna [VerfasserIn]

Links:

Volltext

Themen:

ADAM10
ADAM10 Protein
Amyloid Precursor Protein Secretases
Aspartic Acid Endopeptidases
BACE
BACE2
Bace2 protein, mouse
EC 3.4.-
EC 3.4.23.-
EC 3.4.24.81
Journal Article
Nerve Growth Factors
Neuregulin 2
Neuregulins
Nrg2 protein, mouse
Shedding

Anmerkungen:

Date Completed 29.12.2020

Date Revised 29.12.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s12035-019-01846-9

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM304397938